vTv Therapeutics Inc.

NASDAQ:VTVT

Biotechnology

Healthcare
$16.36 +1.47%

+$0.50 today

Market cap
$64.69M
Beta
0.27
P/E (TTM)
128.7
EPS (TTM)
$0.27
52W Low $14.00High $44.00

Volume 0.02M

Average 0.05M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$32.81M

FY 2025 · Annual

Net Income

-$26.97M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue4.01M2.02M01.02M0
Cost of Revenue00000
Gross Profit4.01M2.02M01.02M0
Gross Margin100.0%100.0%—100.0%—
Research & Development13.32M12.36M13.6M11.55M17.86M
Selling, General & Admin12.34M12.2M11.91M13.65M14.95M
Operating Expenses25.67M24.56M25.5M25.2M32.81M
Depreciation & Amortization89K92K90K89K16K
EBITDA(17.52M)(24.77M)(25.86M)(22.52M)(31.06M)
EBITDA Margin-437.3%-1227.3%—-2214.0%—
Operating Income(21.66M)(22.54M)(25.5M)(24.18M)(32.81M)
Operating Margin-540.9%-1116.9%—-2377.6%—
Interest Income1K352K472K1.57M1.87M
Interest Expense12K15K13K06K
Other Income / Expenses4.05M(2.33M)(464K)1.58M1.73M
Income Before Tax(17.62M)(24.87M)(25.97M)(22.61M)(31.08M)
Pre-Tax Margin-439.9%-1232.6%—-2222.7%—
Income Tax Expense115K200K0100K0
Net Income(12.99M)(19.16M)(20.25M)(18.46M)(26.97M)
Net Margin-324.3%-949.7%—-1815.3%—
EPS (Basic)(8.29)(9.98)(9.71)(3.20)(3.20)
EPS (Diluted)(8.29)(9.98)(9.71)(3.20)(3.20)
Weighted Avg Shares1.57M1.92M2.08M5.77M8.42M
Weighted Avg Shares (Diluted)1.57M1.92M2.08M5.77M8.42M

VTVT Earnings Waterfall · TTM

NASDAQ:VTVT · Revenue to Net Income

Key Ratios

EPS$0.02
Gross Margin25.0%
Net Margin16.4%
P/E Ratio-4.5
P/S Ratio2.3

Analysis

$36.8M of revenue converted into $2.3M of net income for the selected period. Gross margin is 25.0% and net margin is 16.4%, showing how much revenue survives after costs and taxes. EPS is $0.02, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 8, 2026
8-KCurrent reportOct 6, 2026
10-QQuarterly reportAug 6, 2026

How much revenue does VTVT generate?

vTv Therapeutics Inc. (VTVT) reported $0.00 of revenue in fiscal 2025.

Is VTVT profitable?

vTv Therapeutics Inc. (VTVT) reported -$26.97M of net income.